MediPurpose® News

GENEVA and ATLANTA, Jan. 26—MediPurpose®, a master medical product distributor and manufacturer, announced today that its babyLance® infant heel incision device trademark is now protected in Australia.

The Statement of Grant of Protection issued by the World Intellectual Property Organization (WIPO) protects both the word “babyLance” and the neonatal heelstick’s unique blue and green logo.

The medical device’s trademark is also registered in the United States, China, South Korea, Singapore and Switzerland.

The babyLance brand name and logo was designed by MediPurpose with the cooperation of an international graphics consultant who also designed the logo for the SurgiLance® safety lancet and MediPlus™ Advanced Wound Care products.

babyLance is a single-use heel incision device utilized to obtain a blood sample from the heels of newborn (babyLance BLN and preemie (babyLance BLP) infants.

More information about babyLance—including no-cost product sample requests—is available at www.medipurpose.com/babylance/.

About WIPO

The World Intellectual Property Organization is a specialized agency of the United Nations. It is dedicated to developing a balanced and accessible international intellectual property (IP) system, which rewards creativity, stimulates innovation and contributes to economic development while safeguarding the public interest.

WIPO was established by the WIPO Convention in 1967 with a mandate from its Member States to promote the protection of IP throughout the world through cooperation among states and in collaboration with other international organizations. Its headquarters are in Geneva, Switzerland.

For more information about WIPO, please visit www.ipo.int.

About MediPurpose

Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance® heel incision device, SurgiLance® safety lancet and MediPlus™ advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.

EKF’s Point-of-Care Tests to Continue Using SurgiLance Safety Lancets

CARDIFF, Wales and ATLANTA, Jan. 18—MediPurpose®, a master distributor and manufacturer of medical products, today announced its continued partnership with point-of-care (POC) diagnostic equipment manufacturer EKF Diagnostics.

MediPurpose supplies SurgiLance® safety lancets for use with EKF Diagnostics' POC blood analysis equipment, used in tests for glucose, lactate, hemoglobin, hematocrit and HbA1c.

“Supplying OEM medical devices to medical diagnostic manufacturers is a key component of our SurgiLance business model,” said MediPurpose Director of Marketing Derek Rudnak. “EKF Diagnostics’ desire to continue its relationship with MediPurpose is a vote of confidence that speaks to the reliability and quality of our OEM medical products.”

EKF Diagnostics manufactures a range of equipment that analyzes vital organ function through blood values. Its latest offering is the Quo-Lab, which tests the HbA1c levels in the bloodstream. HbA1c values are the best long-range indicators of elevated blood glucose levels and are used in both the detection of pre-diabetes, as well as in monitoring blood sugar control in Type 1 and Type 2 diabetes patients.

SurgiLance is currently available in six models, ranging from 18–26 gauges and 1.0–2.3 mm penetration depths. Valued for its safety, comfort and ease of use, the SurgiLance safety lancet is one of the top selling fingerstick devices in the United States and is available to healthcare professionals through a broad network of distributors, both in the United States and globally.

For more information about SurgiLance safety lancets—including no-cost product sample requests—please visit www.medipurpose.com/surgilance.

About EKF Diagnostics

EKF Diagnostics Holdings, PLC specializes in the development, production and distribution of near-patient analyzers for use in the detection and management of diabetes, anemia, lactate and kidney-related diseases.

EKF Diagnostics has distributors in more than 70 locations around the globe, multi-national research and manufacturing facilities, teams of experienced analysts and engineers in the United States of America, Germany, Ireland and the United Kingdom, and a board led by some of foremost authorities in medical diagnostics in the world.

For more information about EKF Diagnostics, please visit www.ekfdiagnostics.com.

About MediPurpose

Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance® heel incision device, SurgiLance® safety lancet and MediPlus™ advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.

Medical Product Company Also Bids Farewell to President/CSO Randy Prather

ATLANTA, Jan. 12—MediPurpose, a master distributor of medical products, today announced the promotion of Michael Riddle to executive vice president and chief commercial officer (CCO).

“Mike’s promotion reflects both his exemplary performance and his expanding role at the company,” said MediPurpose founder and CEO Patrick Yi.

The promotion is Riddle’s second since joining the medical product company in October 2010 as director of the advanced wound care division and then later promoted to division VP in June 2011.

The promotion is the second for Riddle at MediPurpose. He joined the medical product company in October 2010 as director of its then new advanced wound care division, and was promoted to vice president of advanced wound care in June 2011.

“Mike has been a tremendous asset to the company,” said Yi. “He has been indefatigable in his efforts to help launch and expand the MediPlus™ Advanced Wound Care products brand, and he has consistently demonstrated a solid business acumen that supports MediPurpose’s mission.”

MediPurpose also announced the departure of President/CSO Randy Prather. “Michael will assume all the duties and responsibilities of Randy. I thank Randy for his efforts and contributions during his six years of loyal service to the company, and I wish him all the best in his future endeavors,” said Yi.

About MediPurpose

Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance® heel incision device, SurgiLance® safety lancet and MediPlus™ advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.

New Silver Products Add to Extensive Line of Wound Dressings

ATLANTA, Jan. 4—MediPurpose, a master distributor and manufacturer of medical products, today announced availability of silver foam wound dressings, further expanding its line of MediPlus™ Advanced Wound Care Products.

MediPlus™No-cost evaluation samples of MediPlus’ silver foam wound dressings (also known as Ag foam wound dressings) are offered in three configurations and multiple sizes:

• MediPlus™ Foam Ag: standard non-adherent foam
• MediPlus™ Comfort Foam Border Ag: island dressing with adhesive border
• MediPlus™ Super Foam Ag: highly absorbent with sealed edges to prevent leakage under compression

Wound care professionals and wound care product distributors are able to request no-cost product samples of all MediPlus wound dressings online or by calling MediPurpose’s toll-free number. Downloadable product specification sheets are also available online.

The new silver wound dressings were given 510(k) clearance from the U.S. Food & Drug Administration (FDA) in September 2011. The clearance supports MediPlus’ claims that its silver wound dressings meet the latest standards for antibacterial control established by the FDA and provide an effective barrier to bacterial penetration.

As with the other MediPlus wound care dressings that are currently available for purchase and distribution, the new silver foam dressings will be competitively priced.

“The addition of the silver foam dressings to our product line is an exciting development,” said MediPurpose Vice President–Wound Care Michael Riddle. “Demand for affordable silver wound dressings is very high, and our ability to provide healthcare providers with another cost-effective wound care solution is an integral part of MediPlus’ value proposition.”

Silver foam dressings are indicated for use on a wide range of chronic and traumatic wounds that include ulcers (arterial, diabetic and venous), pressure sores, donor sites, surgical incisions/excisions and first- and second-degree burns.

The MediPlus advanced wound care product line currently features:

• Foams

MediPlus Foam

MediPlus Comfort Foam

MediPlus Super Foam

MediPlus HC Foam

• Hydrocolloids

MediPlus HC (Standard and Extra-Thin)

MediPlus HC Comfort

• Hydrogels

MediPlus Barrier Gel

MediPlus Barrier Gel Comfort

• Non-Adherent Pads

MediPlus PE Pad

• Post-Surgical Dressings

MediPlus PU Pad

MediPlus Surgical

• Thin Films

MediPlus PU Film

MediPlus PU Frame

“As an experienced master distributor, MediPurpose has done all the hard work for medical product distributors seeking to purchase high-quality wound care products at competitive prices,” said Riddle. “Our team of experts has completed all the regulatory, quality, reimbursement and logistics required to import the comprehensive line of MediPlus advanced wound care products.”

More information about MediPlus—including no-cost product sample requests—is available at www.medipurpose.com/mediplus.

About MediPurpose

Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance® heel incision device, SurgiLance® safety lancet and MediPlus™ advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.